Global Blood Therapeutics to Present at the 35th Annual J.P. Morgan Healthcare Conference
January 03, 2017 16:05 ET
|
Global Blood Therapeutics
SOUTH SAN FRANCISCO, Calif., Jan. 03, 2017 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ:GBT) today announced that it will present at the 35th Annual J.P. Morgan Healthcare...
Global Blood Therapeutics Added to NASDAQ Biotechnology Index
December 16, 2016 08:30 ET
|
Global Blood Therapeutics
SOUTH SAN FRANCISCO, Calif., Dec. 16, 2016 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ:GBT) today announced that it has been selected for addition to the NASDAQ Biotechnology...
Global Blood Therapeutics Announces Upcoming Investor Webcast to Review GBT440 Data Being Presented at ASH that Support Sickle Cell Disease Program
November 30, 2016 16:05 ET
|
Global Blood Therapeutics
SOUTH SAN FRANCISCO, Calif., Nov. 30, 2016 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ:GBT), today announced that it will host an investor webcast on Monday, December 5,...
Global Blood Therapeutics Announces Pivotal Study for GBT440 in Sickle Cell Disease with Primary Hemoglobin Endpoint
October 24, 2016 16:05 ET
|
Global Blood Therapeutics
HOPE – A Phase 3 Clinical Trial to Initiate in December Company to Host Conference Call and Webcast Today at 1:30 p.m. PT/ 4:30 p.m. ET SOUTH SAN FRANCISCO, Calif., Oct. 24, 2016 (GLOBE NEWSWIRE)...
Global Blood Therapeutics Announces Appointment of Tricia Suvari as Chief Legal Officer
October 12, 2016 08:00 ET
|
Global Blood Therapeutics
SOUTH SAN FRANCISCO, Calif., Oct. 12, 2016 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ:GBT), a biopharmaceutical company developing novel therapeutics for the treatment...
Global Blood Therapeutics Joins Sickle Cell Disease (SCD) Coalition in Support of SCD Community with Goal to Improve Treatment and Care
September 06, 2016 09:05 ET
|
Global Blood Therapeutics
SOUTH SAN FRANCISCO, Calif., Sept. 06, 2016 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ:GBT), a biopharmaceutical company developing novel therapeutics for the treatment...
Global Blood Therapeutics Announces Participation at Two Upcoming Investor Conferences in September
August 31, 2016 16:05 ET
|
Global Blood Therapeutics
SOUTH SAN FRANCISCO, Calif., Aug. 31, 2016 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ:GBT), a biopharmaceutical company developing novel therapeutics for the treatment...
Global Blood Therapeutics Announces Participation at Three September Conferences
September 03, 2015 07:35 ET
|
Global Blood Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., Sept. 3, 2015 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ:GBT), a biopharmaceutical company developing novel therapeutics for the treatment of...